Last updated: 2026-09-09 05:11:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
SANUWAVE Health, Inc. (SNWV) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $4.17, with a market capitalization of $37.68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.10 to $40.87. This page covers its latest market performance, valuation, price trends and company information.
$37.68M | |
$4.36 | |
$71.25 | |
$0.04 | |
$4.38 | |
49.71K | |
197.24K | |
-- | |
$40.87 | |
$4.10 | |
-- | |
-- |
SANUWAVE Health, Inc. (SNWV) last closed at $4.38 as of 2026-09-08 23:31:00, unchanged from the previous close of $4.38.
During the latest regular trading session, SNWV traded between $0.04 and $71.25, with a volume of 49.71K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, SANUWAVE Health, Inc. (SNWV) moved from $4.66 to $4.17, representing a decline of 10.54% ($0.49).
The stock traded between $4.10 and $4.89 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 34.85 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.2%
SNWV is currently trading at $4.17, placing it 0.2% of the way from its 52-week low of $4.10 to its 52-week high of $40.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 55 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of SANUWAVE Health, Inc. (SNWV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.